期刊
INFECTIOUS MICROBES & DISEASES
卷 4, 期 2, 页码 71-74出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/IM9.0000000000000091
关键词
antiretroviral treatment (ART); drug resistance; human immunodeficiency virus (HIV)
资金
- Ministry of Science and Technology of China [2017ZX10201101002-004, 2018ZX10721102-006]
- China Key Project of the State Key Laboratory of Infectious Diseases Control and Prevention [2019SKLID602]
This paper reviews the prevalence of resistance to HIV reverse transcriptase and protease inhibitors in the HIV-infected population receiving antiretroviral therapy (ART) in China, as well as the population that stopped ART in recent years. Drug resistance is an important factor affecting the mortality of AIDS patients. It is crucial to understand the prevalence and types of drug-resistant strains and their impact on overall AIDS prevention and treatment, especially with the expansion of ART and the widespread use of preventive drugs.
Anti-human immunodeficiency virus (HIV) treatment resistance surveillance has been going on for nearly 18 years in China. In this paper, we review the prevalence in China of resistance to reverse transcriptase and protease inhibitors in the HIV-infected population receiving antiretroviral therapy (ART) and the population that stopped ART in recent years. Drug resistance is an important factor affecting the death of patients with acquired immune deficiency syndrome (AIDS). With the extension of the duration of ART and the expansion of the population receiving ART, especially the widespread promotion of preventive drugs before and after exposure, it is important to obtain insight into the prevalence and types of drug-resistant strains and their impact on the overall AIDS prevention and treatment effect.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据